The physiological aspects of fibrinolysis
- 1 October 1994
- journal article
- Published by Elsevier in Thrombosis Research
- Vol. 76 (1) , 1-31
- https://doi.org/10.1016/0049-3848(94)90204-6
Abstract
No abstract availableThis publication has 172 references indexed in Scilit:
- Plasminogen activators and their inhibitors in non-small cell lung cancer. Low content of type 2 plasminogen activator inhibitor associated with tumor disseminationCancer, 1994
- Circadian fluctuations of tissue plasminogen activator antigen and plasminogen activator inhibitor-1 antigens in vasospastic anginaAmerican Heart Journal, 1992
- Plasminogen activator system in human breast cancerInternational Journal of Cancer, 1992
- Effect of propranolol (long-acting) on the circadian fluctuation of tissue-plasminogen activator and plasminogen activator inhibitor-1The American Journal of Cardiology, 1991
- Clinical significance of plasminogen activator inhibitor activity in patients with exercise-induced ischemiaAmerican Heart Journal, 1990
- Platelets as models: Use and limitationsCellular and Molecular Life Sciences, 1988
- Depression following myocardial infarctionPsychosomatics, 1985
- Effect of cigarette smoking on lipids, lipoproteins, blood coagulation, fibrinolysis and cellular components of human bloodAtherosclerosis, 1975
- Is cerebrospinal fluid the major avenue for the removal of 5-hydroxyindoleacetic acid from the brain?Neuropharmacology, 1973
- FIBRINOLYTIC ACTIVITY IN PREGNANCY, DURING PARTURITION, AND IN THE PUERPERIUMThe Lancet, 1966